Patent ID: 6020123
Filing Date: 2000-02-01
Classification: C07K,C12N,C12Q

Abstract:
An oligonucleotide primer selected from the group consisting of:nucleotides 40-61 (SEQ ID NO:1);nucleotides 9537-9558 (SEQ ID NO: 17);nucleotides 240-259 (SEQ ID NO:18);nucleotides 546-569 (SEQ ID NO:3);nucleotides 906-927 (SEQ ID NO:19);nucleotides 612-633 (SEQ ID NO:5);nucleotides 1857-1876 (SEQ ID NO:7);nucleotides 2078-2101 (SEQ ID NO:20);nucleotides 6275-6299 (SEQ ID NO:9);nucleotides 6855-6878 (SEQ ID NO:11);nucleotides 7548-7573 (SEQ ID NO:21);nucleotides 7782-7805 (SEQ ID NO: 13);nucleotides 8412-8434 (SEQ ID NO: 14);nucleotides 61-82 (SEQ ID NO:22); andnucleotides 9558-9579 (SEQ ID NO:22)of the genome of HIV-2 ROD virus, and nucleotide sequences complementary thereto.